97 related articles for article (PubMed ID: 2805179)
21. [Effect of analogs and antagonists of the thrombocyte-activating factor (PAF) on blood platelet aggregation].
Lakin KM; Kulikov VI; Manevich EM; Muliar AG; Shvets VI
Farmakol Toksikol; 1988; 51(4):113-23. PubMed ID: 2847936
[No Abstract] [Full Text] [Related]
22. Effects of Ro 24-4736 in antagonizing the platelet and bronchoconstrictor responses to PAF.
O'Donnell M
Ann N Y Acad Sci; 1991; 629():416-8. PubMed ID: 1659287
[No Abstract] [Full Text] [Related]
23. Prehispanolone, a novel platelet activating factor receptor antagonist from Leonurus heterophyllus.
Lee CM; Jiang LM; Shang HS; Hon PM; He Y; Wong HN
Br J Pharmacol; 1991 Jul; 103(3):1719-24. PubMed ID: 1657264
[TBL] [Abstract][Full Text] [Related]
24. Influence of plasma protein content and platelet number on the potency of PAF and its antagonist RP 59227 in rabbit platelet preparations.
Floch A; Cavero I
Br J Pharmacol; 1990 May; 100(1):163-7. PubMed ID: 2372657
[TBL] [Abstract][Full Text] [Related]
25. A novel class of platelet activating factor (PAF) antagonists. I. Synthesis and structure-activity studies on PAF-sulfonamide isosteres.
Tsuri T; Haga N; Matsui T; Kamata S; Kakushi H; Uchida K
Chem Pharm Bull (Tokyo); 1992 Jan; 40(1):75-84. PubMed ID: 1605805
[TBL] [Abstract][Full Text] [Related]
26. The enantiomer and the positional isomer of platelet-activating factor.
Tence M; Coëffier E; Polonsky J; Benveniste J
Biochim Biophys Acta; 1983 Feb; 755(3):526-30. PubMed ID: 6824744
[TBL] [Abstract][Full Text] [Related]
27. Biochemical and pharmacological activities of SR 27417, a highly potent, long-acting platelet-activating factor receptor antagonist.
Herbert JM; Bernat A; Valette G; Gigo V; Lale A; LaPlace MC; Lespy L; Savi P; Maffrand JP; Le Fur G
J Pharmacol Exp Ther; 1991 Oct; 259(1):44-51. PubMed ID: 1656029
[TBL] [Abstract][Full Text] [Related]
28. Inhibitory effects of phenol derivatives on bovine platelet aggregation and their effects on Ca2+ mobilization.
Kitagawa S; Ito Y; Oda Y; Kametani F
Biochim Biophys Acta; 1989 Mar; 1011(1):52-7. PubMed ID: 2493810
[TBL] [Abstract][Full Text] [Related]
29. Inhibitory effects of compounds from Zingiberaceae species on platelet activating factor receptor binding.
Jantan I; Pisar M; Sirat HM; Basar N; Jamil S; Ali RM; Jalil J
Phytother Res; 2004 Dec; 18(12):1005-7. PubMed ID: 15742349
[TBL] [Abstract][Full Text] [Related]
30. A role of calcium-activated, phospholipid-dependent protein kinase in platelet-activating factor-induced serotonin release from rabbit platelets.
Ieyasu H; Takai Y; Kaibuchi K; Sawamura M; Nishizuka Y
Biochem Biophys Res Commun; 1982 Oct; 108(4):1701-8. PubMed ID: 7181916
[No Abstract] [Full Text] [Related]
31. Platelet aggregating response to platelet activating factor participates in activation of the 12-lipoxygenase pathway in platelets from rabbits.
Michibayashi T
Int Angiol; 2002 Sep; 21(3):260-7. PubMed ID: 12384648
[TBL] [Abstract][Full Text] [Related]
32. The synthesis and biological evaluation of 10-O-dialkylaminoethyl ginkgolide B as platelet-activating factor antagonist.
Guo CJ; Ren Y; Qin YL; Zhang Q
J Asian Nat Prod Res; 2008; 10(9-10):989-92. PubMed ID: 19003620
[TBL] [Abstract][Full Text] [Related]
33. Selective inhibition of protein kinase C. Effect on platelet-activating-factor-induced platelet functional responses.
Murphy CT; Westwick J
Biochem J; 1992 Apr; 283 ( Pt 1)(Pt 1):159-64. PubMed ID: 1567363
[TBL] [Abstract][Full Text] [Related]
34. Histamine release from rabbit platelets by platelet-activating factor (PAF).
Nakahodo K; Saitoh S; Nakamura M; Kosugi T
Arerugi; 1994 Mar; 43(3):501-10. PubMed ID: 7515227
[TBL] [Abstract][Full Text] [Related]
35. Effects of platelet activating factor on rat platelets in vivo.
Klee A; Schmid-Schönbein GW; Seiffge D
Eur J Pharmacol; 1991 Dec; 209(3):223-30. PubMed ID: 1797563
[TBL] [Abstract][Full Text] [Related]
36. Interaction of the Paf antagonist WEB 2086 and its hetrazepine analogues with human platelets and endothelial cells.
Korth R; Hirafuji M; Keraly CL; Delautier D; Bidault J; Benveniste J
Br J Pharmacol; 1989 Oct; 98(2):653-61. PubMed ID: 2555017
[TBL] [Abstract][Full Text] [Related]
37. Pharmacological activities of a novel thienodiazepine derivative as a platelet-activating factor antagonist.
Tsunoda H; Sakuma Y; Harada K; Muramoto K; Katayama S; Horie T; Shimomura N; Clark R; Miyazawa S; Okano K
Arzneimittelforschung; 1990 Nov; 40(11):1201-5. PubMed ID: 2085331
[TBL] [Abstract][Full Text] [Related]
38. Translocation-independent activation of protein kinase C by platelet-activating factor, thrombin and prostacyclin. Lack of correlation with polyphosphoinositide hydrolysis in rabbit platelets.
Salari H; Duronio V; Howard S; Demos M; Pelech SL
Biochem J; 1990 May; 267(3):689-96. PubMed ID: 2160234
[TBL] [Abstract][Full Text] [Related]
39. Effects of tetrandrine on rabbit platelet aggregation and platelet activating factor generation.
Zhang M; Zhang LZ; Lu JS
Zhongguo Yao Li Xue Bao; 1995 May; 16(3):209-12. PubMed ID: 7660812
[TBL] [Abstract][Full Text] [Related]
40. Dual effects of oleic acid on Ca2+ mobilization and protein phosphorylation in human platelets in presence or absence of platelet activating factor.
Kimoto M; Javors MA; Ekholm J; Siafaka-Kapadai A; Hanahan DJ
Arch Biochem Biophys; 1992 Nov; 298(2):471-9. PubMed ID: 1384432
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
